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Introduction
Necrotising fasciitis is a severe form of soft tissue infection that primarily involves the 
superficial fascia. It may result from any insult to the integumentary system or from 
haematogenous spread. It can develop at the site of a skin biopsy, laceration, insect bite, 
needle puncture, surgical wound, skin abscess, and areas affected by herpes zoster, or a 
chronic venous ulcer. It may spread rapidly to involve a whole limb, for which reason early 
debridement and antibiotic interventions are essential to avoid a fatal outcome. The two 
commonest pitfalls in management are: failure to make an early diagnosis and inadequate 
surgical debridement.
 Necrotising fasciitis places significant demands upon hospital and medical resources. 
In the US, the annual age-adjusted incidence was 4.3 invasive infections per 100 000 of 
the population.1 An Australian study2 reported that the mean hospital length of stay for 
survivors of necrotising fasciitis was 36 days, and the average cost per patient during their 
hospital stay was AUS$64 517. For the 63% of their patients admitted to the Intensive Care 
Unit (ICU), the average length of stay in the ICU was 11 days. A similar average duration 
of hospitalisation (34 days) was reported from Taiwan.3 In Hong Kong, the numbers of 
 Objective To review currently available evidence on the epidemiology and 
methods of management for necrotising fasciitis, with particular 
reference to Hong Kong.
 Data sources Medline, PubMed, and Cochrane Library searches of local and 
internationally published English language journals, from 1990 
to July 2008 using the terms ‘necrotising fasciitis’, ‘Hong Kong’, 
‘diagnosis’, ‘epidemiology’, ‘vibrio’, ‘streptococci’, ‘clostridia’, and 
‘management’.
 Data extraction All articles involving necrotising fasciitis in Hong Kong were 
included in the review.
 Data synthesis The incidence of necrotising fasciitis in Hong Kong and around 
the world has been increasing. This rapidly progressive infection 
is a major cause of concern, due to its high morbidity and 
mortality. Up to 93% of affected patients at our hospital were 
admitted to the Intensive Care Unit and many still died from 
septic complications, such as pneumonia and multi-organ 
failure. Radical debridements in the form of amputations and 
disarticulations were considered vital in 46% of the patients. 
Early recognition and treatment remain the most important 
factors influencing survival. Yet, early diagnosis of the condition 
is difficult due to its similarities with many other soft tissue 
disorders such as cellulitis. Repeated surgical debridement or 
incisional drainage continues to be essential for the survival 
of sufferers from necrotising fasciitis. Many authorities have 
reported that carrying out the first fasciotomy and radical 
debridement within 24 hours of symptom onset was associated 
with significantly improved survival, which also emphasises the 
importance of early diagnosis.
 Conclusion Clinicians must adopt a high index of suspicion for necrotising 
fasciitis. Empirical antibiotics must be started early and repeated 
physical examinations should be performed, while maintaining 
a low threshold for tissue biopsy and surgery. The timing of the 
first fasciotomy and radical debridement within a window of 
24 hours from symptom onset is associated with significantly 
improved survival.
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	 目的	 回顧壞死性筋膜炎流行病學和處理方法的現有實證，
尤其是針對香港的研究。
	 資料來源	 使用以下關鍵詞，搜索從1990年至2008年7月於
Medline、PubMed及Cochrane Library發表過的本地及
外國的英文文獻：‘necrotising fasciitis’「壞死性筋
膜炎」、‘Hong Kong’「香港」、‘diagnosis’「診
斷」、‘epidemiology’「流行病學」、‘vibrio’「弧
菌」、‘streptococci’「鏈球菌」、‘clostridia’「梭
狀芽胞桿菌」，和‘management’「處理」。
	 資料選取	 所有關於香港發生的壞死性筋膜炎的文獻都被納入回
顧範圍內。
	 資料綜合	 壞死性筋膜炎無論在香港或全世界都有上升的趨勢。
由於患病率及死亡率很高，這種快速惡化的感染病很
值得關注。我們的醫院接近93%受影響的病人須入住
深切治療部，當中很多因為患上如肺炎和多器官衰竭
的膿毒症而死亡。46%的病人中，發現截肢術和關節
離斷術的積極清瘡方法很重要。早期識別和處理是影
響存活率的最重要因素。可是，由於此病與很多其他
軟組織病如蜂窩織炎很相似，所以早期診斷尤其困
難。不斷重複的清瘡術和切開引流術對於維持壞死性
筋膜炎病人的生命仍然相當重要。很多機構的報告顯
示，在出現徵兆的24小時內進行首次筋膜切開術及積
極清瘡術，與存活率有顯著關係；這亦表明早期識別
此病的重要性。
	 結論	 醫生必須對壞死性筋膜炎提高警惕。病人應盡早服用
抗生素及重複進行健康體檢，同時維持低程度的組織
活檢和手術。在出現徵兆的24小時窗口期內進行首次
筋膜切開術及積極清瘡術的時間性，與存活率的提高
有顯著關係。
肢體壞死性筋膜炎的回顧
registered discharges from hospital and deaths due 
to necrotising fasciitis have been increasing. The 
crude death rate (number of registered deaths per 
100 000 inhabitants) due to fasciitis in Hong Kong 
increased from 0.1 in 2001 to 0.4 in 2006 (Table 1).4 In 
the recent few years (2005-July 2008), four out of 30 
patients succumbed to necrotising fasciitis (Table 2).5
Methods
A literature search using electronic databases, 
including Medline, PubMed, and the Cochrane Library 
was performed. Search terms included ‘necrotising 
fasciitis’, ‘Hong Kong’, ‘diagnosis’, ‘epidemiology’, 
‘vibrio’, ‘streptococci’, ‘clostridia’, and ‘management’. 
The same investigator screened each article for 
inclusion. Major inclusion criteria were articles that 
(i) were published in the English language from 
1990 up to and including July 2008, and (ii) involved 
necrotising fasciitis in the extremities. Major exclusion 
criteria were articles on Fournier’s gangrene. Articles 
were reviewed and data regarding the epidemiology, 
causative agents, diagnosis methods, management, 
and long-term outcomes (such as mortality and 
survival) were retrieved. Bibliographies of review 
articles were reviewed for potentially relevant studies 
not identified through the electronic searches. All 
articles describing necrotising fasciitis in Hong Kong 
were included in this review. The same investigator 
undertook the data extraction from these articles. 
One article describing the location of vibrio species 
found in Hong Kong waters published in 1986 was also 
included because of its noteworthy information.6
Risk factors
The majority of patients with necrotising fasciitis 
(82%) had some form of chronic debilitating diseases 
such as diabetes mellitus, alcohol abuse, or renal 
insufficiency.7 Of these conditions, diabetes mellitus 
was the most common, being present in 57% of the 
patients according to one report.8 The implication of 
diabetes mellitus as a co-morbidity was important, as 
a higher percentage of these patients succumbed to 
the necrotising fasciitis (83% vs 37%, P=0.047).9 Being 
immunocompromised (17% of the patients in one 
sample) was also an important predictor of mortality 
(odds ratio [OR]=3.97; 95% confidence interval [CI], 
1.04-15.19; P=0.044).10
 There was no consensus in the medical 
literature about any association between exposure 
to non-steroidal anti-inflammatory drugs (NSAIDs) 
and susceptibility to necrotising fasciitis. One study, 
however, claimed that there was such an association 
(adjusted OR=31.4; 95% CI, 6.4-153.8).11 As NSAIDs 
inhibit prostaglandins, the authors suggested that 
與研究選取
Year No. of 
registered 
deaths
Crude death rate (number 
of registered deaths per 
100 000 inhabitants)
2001 7 0.1
2002 15 0.2
2003 14 0.2
2004 4 0.1
2005 25 0.4
2006 24 0.4
TABLE 1. Numbers of registered deaths and crude death rates 
due to fasciitis, not elsewhere classified (ICD10:M725), 2001-2006
Year Reported cases
2005 12
2006 3
2007 11
2008 (up to July) 4
TABLE 2. Numbers of patients with necrotising fasciitis 
reported to the Centre for Health Protection, Hong Kong 
(2005-July 2008)
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this results in an altered inflammatory response to 
the responsible organisms. Moreover, as NSAIDs 
suppress the cytoprotective effects of prostaglandins, 
it was suggested they might potentiate the 
development of acute renal failure (via inhibition of 
renal prostaglandin synthesis).
Causative agents
Necrotising fasciitis is usually divided into two 
categories. Type I disease (polymicrobial) involved 
anaerobic bacteria and streptococci other than 
serogroup A, and type II disease (monomicrobial) 
was caused by group A streptococci (GAS).12 There 
was no consistent evidence on which type was more 
common. Taiwanese studies showed 20 to 38% of 
patients had polymicrobial disease and 49 to 68% had 
monomicrobial disease.3,13 Monobacterial infection 
was most commonly due to Streptococcus pyogenes 
(25% of cases).14 In US studies, however, 71 to 75% 
of tissue culture isolates yielded mixed aerobic and 
anaerobic bacteria.14 A Turkish study found 82% of 
cases had polymicrobial infections.15 Worldwide, 
GAS was the commonest pathogen responsible; the 
two most common portals of entry being sites of 
prior trauma and skin lesions (44.8% of patients).3 
Yet, of 30 patients with necrotising fasciitis in Hong 
Kong during the recent few years, 25 (83%) of the 
relevant tissue cultures grew vibrio, whilst only four 
(13%) grew S pyogenes, and one (3%) was diagnosed 
clinically without a culture result.5
 The most prevalent types of GAS in Hong Kong 
were M1 (15%) and M12 (21%)16; these two types were 
usually found in skin and throat isolates and were 
most commonly associated with invasive disease (64% 
of cases). Notably, M1 was more frequent in invasive 
than non-invasive isolates (8/24 vs 8/83, P=0.004).16 
The case-fatality rate of GAS giving rise to necrotising 
fasciitis was approximately 20%.17 The virulence of the 
M1 type may be related to its ability to increase the 
adhesion of streptococci to tissues and thus prevent 
phagocytosis by neutrophils.
 In Hong Kong and other coastal cities around 
the world, another common pathogen responsible 
for necrotising fasciitis was the vibrio species, for 
which fishermen are an occupation group at risk.18 
The relevant vibrio species are common in seawater 
and have been isolated from brackish waters and 
seafood.19 The organisms are halophilic (require 
high concentrations of salt for growth), motile, and 
encountered in warm coastal waters during the 
warmer months of summer,19 and high concentrations 
have been found in shellfish, especially oysters.20 
Exposure to these bacteria usually occurs through 
ingestion of shellfish or inoculation via traumatic 
injury in marine environments.20,21 Up to 50% of 
oysters and 11% of crabs cultured positive for the 
organism during summer months, when the incidence 
of vibrio infections peaks.21 The highest densities of 
vibrio species in Hong Kong were detected in water 
samples from the Aberdeen shelter and the Jordan 
ferry pier.6
 In necrotising fasciitis due to Vibrio vulnificus, 
predisposing factors included chronic liver 
disease (haemochromatosis and cirrhosis), adrenal 
insufficiency, malignancy, immunocompromised 
states such as AIDS and achlorhydria.20 High serum 
iron levels appear to predict severe infections, 
very likely related to iron sequestration from 
transferrin and haemoglobin and the production 
of siderophores.20 Thus, cirrhosis also appears to 
be an important risk factor, due to its relation to 
dysfunctional iron metabolism, portal drainage, and 
impaired hepatocellular function.
 In the last decade, cases of necrotising fasciitis 
caused by other strains of vibrionaceae have also been 
reported. In Hong Kong, Vibrio alginolyticus infections 
have followed injuries inflicted by stingrays, and 
Vibrio damsela infections after rabbitfish injuries.22-24 
These organisms are more virulent than V vulnificus 
and cause rapidly advancing necrotising fasciitis. 
Very early surgical debridement and amputation may 
be required for survival.24
 Other bacteria commonly associated with 
necrotising fasciitis include Aeromonas and the 
clostridia species. Aeromonas, like vibrio, are 
very virulent; in one Taiwanese study all infected 
patients died.3 Aeromonas hydrophilia infections are 
encountered in association with immunosuppression, 
burns, or trauma; 78% of cases had recent exposure 
to contaminated freshwater.25,26
 Injection drug abuse and prior surgery 
were risk factors of necrotising fasciitis caused by 
clostridia.27,28 Most of these bacteria are killed by brief 
heating to temperatures of 72ºC, but their spores are 
more resistant to heat.29 Thus, infection is possible 
after contact with instruments to which heating 
procedures have been applied. Clostridial infections 
are also associated with bowel surgery; infections with 
Clostridium perfringens have been encountered after 
procedures such as laparoscopic cholecystectomy.30
Pathogenesis
Most bacteria and fungi multiply within viable tissue, 
but fibrous attachments between subcutaneous 
tissues and fascia can help limit the spread of infection. 
The natural lack of fibrous attachments in larger areas 
of the body such as the trunk or extremities facilitates 
widespread infection.31 The primary site of such 
pathology is the superficial fascia; the mechanism of 
spread being attributed to the expression of bacterial 
enzymes such as hyaluronidase (which degrade 
fascia).32 Uncontrolled proliferation of bacteria causes 
angiothrombotic microbial invasion and liquefactive 
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necrosis of the superficial fascia.32 The infection 
spreads along fascial planes, causing widespread 
thrombosis of perforating nutrient vessels to the skin 
and progressive skin ischaemia.32,33
 This is the underlying event responsible for 
the cutaneous manifestations of evolving necrotising 
fasciitis. Initially a horizontal phase predominates 
with rapid spread through the fascia with extensive 
undermining of apparently normal-looking skin. As 
the condition evolves, ischaemic skin necrosis ensues 
and manifests as gangrene in subcutaneous fat, the 
dermis, and epidermis, followed by progressive 
bullae formation, ulceration, and skin necrosis.32
Clinical stages
The clinical presentation of necrotising fasciitis entails 
progressive skin changes. Early on, only tenderness, 
swelling, erythema, and warm skin are present 
and specific signs such as crepitus and blistering 
are rare (Fig 1a).32,34,35 In an Indian study involving 
75 patients, 91% of patients presented with local 
tenderness, 99% with oedema, 72% with erythema, 
73% with ulceration, and 72% with a purulent or 
serous discharge.36 Occasionally, some patients had 
unstable presentations. Some US studies reported 
that in addition to common presenting symptoms 
such as swelling and redness (in 78-100% of cases), 
83% of patients had severe pain, 86% had fever, and 
33% also had hypotension (systolic blood pressure, 
<90 mm Hg), 23% were also disorientated and 24% 
experienced local anaesthesia.28,37,38 Rarer symptoms 
such as crepitus and blistering were also noted (in 
<40% of patients).28,37,38 In a Hong Kong study of 24 
patients, 79% presented with toxic shock but the 
most consistent symptom was severe pain (present 
in all patients).39 In the same study, tenderness and 
generalised swelling of the limb was observed in 58% 
of the patients, erythema in 50%, and skin oedema 
in 13%.
 When critical skin ischaemia occurs, blisters 
or bullae are formed, such an appearance being 
rare in cellulitis or erysipelas.32,34 Blistering is due 
to ischaemia-induced necrolysis as the invading 
organisms cause progressive thrombosis of vessels 
that penetrate the fascia to supply the skin.32
 In their late stage, necrotising fasciitis lesions 
turn black and form a necrotic crust (Fig 1b),34 with 
fascial tissue and brown grayish secretions underneath 
the crust.34 The occurrence of tissue necrosis results 
in hyposensitivity (or anaesthesia) as the nerves 
become involved.34 The subcutaneous cellular tissue 
was friable and could be easily removable.34 Tissue 
crepitation was present due to the gas produced by 
aerobic and anaerobic bacteria.34 Characteristically 
the skin becomes more erythematous, painful 
and swollen, and also displays indistinct borders,34 
violaceous hues, and necrotic bullae.40 The skin 
eventually becomes haemorrhagic and gangrenous. 
Table 3 summarises the stages.40
Clinical diagnosis
Diagnosis of necrotising fasciitis depends on 
recognition of the characteristic rapidly progressive 
clinical course.41 There could be a history of soft 
(a)
(b)
FIG 1. (a) Early stage of necrotising fasciitis with only erythema 
and oedema. (b) Late stage of necrotising fasciitis with 
haemorrhagic bullae and blistering
Stage 1 Stage 2 Stage 3
Tenderness Blisters and bullae formation Tissue necrosis
Erythema Hyposensitivity
Oedema Anaesthesia
Warm skin Tissue crepitation
Fever Haemorrhagic bullae
TABLE 3.  Clinical stages of necrotising fasciitis
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tissue injury from an animal or insect bite, blunt 
or penetrating trauma, minor skin infection, 
postoperative infection, or even injections (eg 
subcutaneous insulin or illicit drugs).31,36
 Due to overlapping diagnostic characteristics 
between cellulitis and necrotising fasciitis, initially 
many patients were mistakenly diagnosed as cellulitis, 
resulting in delayed management. Usually, pain out 
of proportion to the physical findings is the only early 
distinguishing feature. In cellulitis, infection begins 
at the junction between the dermis and superficial 
fascia, but in necrotising fasciitis it starts at the level 
of subcutaneous fat and deep fascia, and in the early 
stages the epidermal and dermal layers are spared.39 
Oedema of the epidermal and dermal layers and 
erythema of skin are therefore not obvious initially.39
 However, a number of symptoms and signs 
that may help differentiate the two conditions 
have been proposed. A Canadian study described 
patients with necrotising fasciitis as more likely to 
have a generalised erythematous rash (OR=11.0; 
95% CI, 2.0-262.5) and a toxic appearance (OR=23.0; 
95% CI, 2.0-262.5).42 The responsible organisms 
produce pyogenic exotoxins and cytolysin that are 
responsible for hypotension, multi-organ failure, and 
disseminated intravascular coagulation.39 Patients with 
necrotising fasciitis were also more likely to have low 
platelet counts at presentation (mean, 194.0 x 109 /L
for necrotising fasciitis vs 299.3 x 109 /L for cellulitis, 
P=0.03).42 Thrombosis of skin vessels leads to necrosis 
and the severe pain fades as nerves die.39
Surgical diagnosis
The gold standard for detecting necrotising soft 
tissue infections is tissue biopsy obtained at the time 
of wound exploration and surgical debridement.31 
During wound exploration, tissue integrity and depth 
of invasion can also be evaluated. Presence of fascial 
necrosis and myonecrosis are indicative of necrotising 
infection. Loss of fascial integrity along tissue planes 
and frank evidence of muscle involvement are also 
diagnostic (Fig 2).31
 A bedside procedure that aids diagnosis is the 
‘finger test’. A 2-cm incision down to the deep fascia 
is made under local anaesthesia, and the level of the 
superficial fascia is then probed with a gloved finger. 
Lack of bleeding, foul-smelling ‘dishwater’ pus, 
and minimal tissue resistance to finger dissection 
indicate a positive finger test,32,33 and are considered 
diagnostic of necrotising fasciitis.
 In necrotising fasciitis, the operative findings 
include the presence of dusky gray subcutaneous 
fat and fascia with a scanty serosanguineous 
discharge.33 Also there is a lack of resistance to blunt 
dissection of the normally adherent superficial fascia, 
accompanied by a lack of bleeding and the presence 
of foul-smelling ‘dishwater’ pus.32 Surgical diagnosis 
also involves examination of frozen sections after 
exploration of suspect areas to look for neutrophil 
infiltrates at wound margins.
Management options
Prompt diagnosis, adequate support to maintain 
vital functions, as well as thorough and frequent 
surgical debridement are the mainstay for achieving 
a successful outcome. According to published 
reports, a mean of three debridements controlled the 
infective process,3 and survivors underwent a mean 
of 3.8 operations and fascial excision of up to 35% of 
the total body surface area.43 Significant morbidity 
and mortality due to toxaemia, dehydration, and 
severe biochemical disturbances were reported to 
occur, whenever treatment was delayed.44 A US study 
indicated that aggressive surgical debridement at the 
outset was associated with a mortality rate of 4.2%, 
versus 38% after delayed treatment (P=0.0007).45 In 
another US study, 17 of 29 patients who underwent 
early operation (within 24 hours of admission) had a 
6% mortality, while after delayed surgery it was 25%.46 
This finding was consistent with a Singaporean study 
(surgery delayed by more than 24 hours increasing 
mortality; relative risk=9.4, P<0.05) and a Taiwanese 
study (early debridements conferred a lower mortality 
than after delayed operations; 26% vs 46%, P=0.069).3,47 
The timing of the first fasciotomy within 24 hours of 
injury enhanced survival when compared to later 
surgery (hospital mortality 5% vs 23%, P=0.005).48
 Although surgical debridement or incisional 
drainage is essential to survival in patients with 
necrotising fasciitis, use of appropriate antibiotics 
is equally important. Since the condition is usually 
polymicrobial, the initial regimen should include 
agents effective against aerobic Gram-positive cocci, 
Gram-negative rods, and anaerobes. The mainstay 
antibiotic regimen consists of a combination of 
FIG 2. Intra-operative photo of debridement procedure
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penicillin and clindamycin.49 Clindamycin is often 
used because of a 68% failure rate attributed to lone 
use of cell wall–inhibiting antibiotics.50 In these deep 
infections, adding an inhibitor of protein synthesis has 
a more favourable outcome (83% vs 14%, P=0.006).50 
Clindamycin also facilitates phagocytosis of GAS 
by inhibiting M protein synthesis. A combination 
of ciprofloxacin and amoxicillin-clavulanate was 
successful in treating necrotising fasciitis caused by 
V alginolyticus.22 The overall rate of erythromycin 
resistance in GAS isolates in Chinese patients was 
92%, compared to reported rates of 2.1 to 4.6% in the 
US and Canada.51 In Hong Kong, the resistance rate to 
erythromycin was 32%.16 There was also a high (53%) 
rate of resistance to tetracycline,16 reflecting a high 
level of indiscriminate local usage.
 Hyperbaric oxygen (HBO) therapy involves 
placing the patient in an environment of increased 
ambient pressure while breathing 100% oxygen, and 
results in enhanced oxygenation of arterial blood and 
tissues.52 This significantly increases tissue oxygen 
tension, resulting in bacteriostasis of clostridia and 
halting the production of their α-toxin.52 Infected 
tissue is known to be hypoxic through a combination of 
poor perfusion and oedema, whereas HBO improves 
neutrophil function by raising tissue oxygen tension. 
Hypoxia reduces the effectiveness of several antibiotics 
such as vancomycin and ciprofloxacin, but potentiates 
the action of aminoglycosides (as microorganism 
expel these drugs via an oxygen-dependent pump).52 
Once the infection is controlled, HBO-induced 
fibroblast proliferation and angiogenesis appear to 
assist wound closure.12,52 In a US review, on average, 
HBO-treated patients achieved wound closure 28 
days after first debridement compared to 48 days in 
those not receiving such therapy.38 In an Australian 
study, two out of 33 (6%; 95% CI, 1-20%) HBO-
treated patients died, compared to 4 of 11 (36%; 
95% CI, 11-69%) among those not receiving such 
therapy (P=0.03).52 This amounted to a relative risk 
reduction of 83%, and corresponded to an OR for 
survival of 8.9 (95% CI, 1.3-58.0). A study from the US 
involving 42 patients showed that HBO adjunctive to 
comprehensive, aggressive debridements reduced 
mortality compared to controls not receiving HBO 
(12% vs 34%), and morbidity (amputations being 
reduced 50% vs 0%).53 However such findings are 
not reported consistently. In a Canadian study of 30 
patients treated with HBO therapy and 24 treated 
without it, mortality rates for the respective groups 
were 30% and 42%, which was not a statistically 
significant difference.54
 Use of HBO therapy in Hong Kong has been 
limited. The Recompression Treatment Centre on 
Stonecutters Island was opened in April 1994 and 
was mostly used for diving-related incidents.55 Less 
than 5% of all patients admitted to the treatment 
centre received HBO for conditions other than 
decompression sickness, carbon monoxide 
poisoning, or radionecrosis.55 This may have been 
due to the remote location of the facility and the risk 
of transporting critically ill patients.
 Intravenous immunoglobulin (IVIG) has been 
shown to reduce mortality in necrotising fasciitis 
associated with the toxic shock syndrome, possibly by 
neutralising superantigen activity of beta-haemolytic 
streptococci on cytokine release by T cells and by 
reducing plasma levels of tumour necrosis factor and 
interleukin-6.49,56 Intravenous immunoglobulin given 
to patients with streptococcal toxic shock syndrome 
yielded a 67% 30-day survival, versus 34% in controls.57 
Accordingly, with IVIG therapy, the OR for survival 
was 8.1 (95% CI, 1.6-45; P=0.009).57 An Australian study 
reported that patients receiving IVIG had an overall 
survival rate of 80%, but there was no significant 
reduction of the case fatality rate.12
Sequelae
Due to difficulties in diagnosing necrotising fasciitis, 
the condition is associated with high rates of morbidity 
and mortality. An Australian study reported that out 
of 14 patients, 93% were admitted to the ICU, 79% 
required mechanical ventilation, and 71% received 
inotropic support.12 In a US study, of 46 patients with 
necrotising fasciitis, 28 (61%) were admitted to the 
ICU.58
 Urgent limb amputation is performed in patients 
with irreversible necrotic changes following sepsis 
and failed multiple debridements.59 In Turkey, nine 
(41%) of 22 such patients had below- or above-knee 
amputations.60 In the UK, out of 451 such patients, 
22.3% underwent amputation or limb disarticulation.59 
In Taiwan, amputation was performed to control 
infections in 12% of patients out of a total of 59,3 and 
in Hong Kong radical debridements (amputations 
and disarticulations) were performed in 46% of 24 
patients.39
 Despite efforts to treat the rapid infective 
process, many patients still die through complications 
of sepsis (pneumonia, heart failure, and metabolic 
disturbance).61 The mortality rate of necrotising 
fasciitis ranges from 20 to 75%.15,61 In a US study, 
four (33%) of 12 patients died with multi-organ 
failure.61 Admission with white cell counts exceeding 
30 x 109 /L, hyperkalaemia, high partial thromboplastin 
times and aspartate aminotransferase levels, low 
arterial pH and bicarbonate concentrations all 
predicted mortality.62,63 A Taiwanese study showed 
that vibrio infections, aeromonas infections, 
hypotension, and malignancies were associated 
with a higher mortality rate (P<0.05), while the 
presence of haemorrhagic bullae was associated with 
reduced mortality (P<0.05).64 Patients who died were 
significantly older than survivors (P=0.038).60
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Discussion
The incidence of necrotising fasciitis has been 
increasing in Hong Kong and around the world. Due 
to difficulties in diagnosis and management of this 
condition, it is a growing concern for health care 
providers.
 Early recognition of necrotising fasciitis is 
difficult, even for experienced clinicians. Yet, certain 
clinical settings should raise suspicions. Patients 
with diabetes mellitus, compromised immunity, and 
a history of intravenous drug abuse are particularly 
at risk, and in them there is an increased mortality. 
The public should also be aware of the risks and 
the common clinical symptoms associated with 
necrotising fasciitis; affected individuals must seek 
medical attention immediately.
 One of the most challenging aspects of 
necrotising fasciitis is its similarities with cellulitis, 
initially at least. The distinction is crucial, as cellulitis 
responds readily to antibiotic treatment alone, 
whereas in patients with necrotising fasciitis, survival 
also depends on early extensive surgical drainage 
and debridement, or even amputation. Necrotising 
fasciitis is more likely if the patient presents with a toxic 
appearance and/or there is crepitus and blistering. 
However, this is rare and usually both conditions 
present with the classic inflammatory features: pain, 
swelling, erythema, fever, and warm skin. Interestingly 
though, studies from Hong Kong reported a greater 
proportion with toxic manifestations than in other 
countries,39 possibly due to late presentations to 
hospitals, limited public awareness, or more virulent 
vibrio species encountered locally. The period 
elapsing between symptom onset and admission into 
hospital could be an interesting direction for further 
studies.
 The two most common organisms encountered 
in Hong Kong were streptococci and vibrio species. 
Vibrio in particular is highly virulent and particularly 
encountered by seafood handlers. Prevention 
measures therefore include: wearing gloves by those 
handling raw seafood, eating adequately cooked 
seafood, and avoiding raw oysters, clams, shrimp, 
and fish (associated with a high carriage rate of vibrio 
by high-risk individuals). Exposure of open wounds 
to seawater or raw seafood should also be avoided, 
especially in warm weather. One study pointed out 
the need for a high index of suspicion in regions 
endemic for vibrio necrotising fasciitis, and even 
suggested that antibiotic prophylaxis should be given 
to swimmers before entering such waters.59
 The importance of early surgical management 
has been stressed in every study. Many articles 
reported that the timing of first fasciotomy and 
debridement (within a window period of 24 hours 
from symptom onset) was critical to improving 
survival. Yet, this poses a dilemma. Namely, is surgical 
exploration necessary in every case of suspected 
invasive soft tissue infection? The yield may not be high 
and could pose a huge burden on pathologists and 
surgeons. As yet there is no consensus on resorting 
to radical surgery in terms of amputations versus 
limb salvage surgery and repeated debridements. 
The authors recommend that surgeons should aim 
at limb salvage surgery as long as the patient’s life 
is not compromised. Currently there is no evidence 
to support amputation in the early stages. Achieving 
better function versus the risks from disease severity 
must be balanced in the individual clinical setting 
(Table 4).
 This review alerts clinicians to a high index 
of suspicion for necrotising fasciitis, which has an 
aggressive clinical course and can progress rapidly 
(within hours). Investigations such as computed 
tomography and magnetic resonance imaging can 
help diagnose necrotising fasciitis at presentation, 
but these imaging tools take time to process and 
may delay management. The most reliable approach 
is to have increased clinical awareness. Complaints 
of pain out of proportion to the visible findings or 
excruciating tenderness are clinical aids to early 
diagnosis. Upon admission, the general approach to 
soft tissue infections is to start empirical antibiotics, 
as most conditions such as cellulitis will respond. If 
the infection persists despite antibiotics, repeated 
physical examinations should be performed whilst 
maintaining a low threshold for tissue biopsy and 
surgery. If significant changes such as blistering, 
shock, or hyposensitivity ensue within hours, there 
should be no hesitation in proceeding to surgery. 
Where the progression is less pronounced, tissue 
biopsy should be performed. It is safer to treat these 
ambiguous cases as necrotising fasciitis and manage 
them aggressively, as delay in treatment can be life-
threatening.
Limb salvage surgery Amputation 
Good past health
Not life-threatening state
Multiple sites
Responsive to inotropic support
Concurrent medical disease with high 
anaesthetic risk from multiple operations (eg 
poorly controlled diabetes mellitus, valvular 
heart disease)
Myonecrosis
Unremitting shock
Concurrent peripheral vascular insufficiency
Rapidly progressive infection
Large area of tissue necrosis (heel pad and 
sole skin loss)
TABLE 4.  Factors favouring limb salvage surgery versus amputation
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